Stericycle, Inc., together with its subsidiaries, provides regulated and compliance solutions to the healthcare, retail, and commercial businesses in the United States and internationally. It operates through three segments: Domestic and Canada Regulated Waste and Compliance; International Regulated Waste and Compliance; and Domestic Communication and Related Services. It collects and processes regulated and specialized waste for disposal services; and collects personal and confidential information for secure destruction, recall/return, and communication services. The company's services also include medical waste disposal, pharmaceutical waste disposal, hazardous waste management, sustainability solutions for expired or unused inventory, secure information destruction of documents and e-media, and compliance services; and regulated recall and returns management communication, logistics, and data management services for expired, withdrawn, or recalled products. In addition, it offers compliance programs under the Steri-Safe, Clinical Services, First Practice Management, SeguriMed, and EnviroAssure brand names; and live voice and automated communication services, including afterhours answering, appointment scheduling, appointment reminders, secure messaging, and event registration. The company serves healthcare businesses, including hospitals, physician and dental practices, outpatient clinics, long-term care facilities, etc.; retailers and manufacturers; financial and professional service providers; governmental entities; and other businesses. Stericycle, Inc. was founded in 1989 and is headquartered in Lake Forest, Illinois.
Industry, Sector and Symbol
Industry Sanitary services
Sub-IndustryEnvironmental & Facilities Services
SectorBusiness Services
Phone847-367-5910
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$3.49 billion
Profitability
Miscellaneous
Employees22,500
Next Earnings Date5/2/2019 (Confirmed)
OptionableOptionable
Stericycle (NASDAQ:SRCL) Frequently Asked Questions
What is Stericycle's stock symbol?
Stericycle trades on the NASDAQ under the ticker symbol "SRCL."
How were Stericycle's earnings last quarter?
Stericycle Inc (NASDAQ:SRCL) announced its quarterly earnings data on Thursday, February, 28th. The business services provider reported $1.03 earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of $0.96 by $0.07. The business services provider earned $852.70 million during the quarter, compared to analysts' expectations of $848.75 million. Stericycle had a positive return on equity of 14.19% and a negative net margin of 7.02%. View Stericycle's Earnings History.
When is Stericycle's next earnings date?
How can I listen to Stericycle's earnings call?
Stericycle will be holding an earnings conference call on Thursday, May 2nd at 5:00 PM Eastern. Interested parties can register for or listen to the call using this link or dial in at 8665166872.
What guidance has Stericycle issued on next quarter's earnings?
Stericycle issued an update on its FY 2019 earnings guidance on Thursday, February, 28th. The company provided earnings per share guidance of $3.32-3.72 for the period, compared to the Thomson Reuters consensus estimate of $4.20. The company issued revenue guidance of $3.408-3.533 billion, compared to the consensus revenue estimate of $3.49 billion.
What price target have analysts set for SRCL?
7 equities research analysts have issued 12 month price targets for Stericycle's stock. Their predictions range from $44.00 to $75.00. On average, they expect Stericycle's stock price to reach $56.6667 in the next year. This suggests that the stock has a possible downside of 1.9%. View Analyst Price Targets for Stericycle.
What is the consensus analysts' recommendation for Stericycle?
7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Stericycle in the last year. There are currently 2 sell ratings, 2 hold ratings and 3 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Stericycle.
What are Wall Street analysts saying about Stericycle stock?
Here are some recent quotes from research analysts about Stericycle stock:
- 1. According to Zacks Investment Research, "Stericycle’s fourth-quarter 2018 earnings and revenues beat the Zacks Consensus Estimate. The company is making progress with Business Transformation initiatives, aimed at improving long-term operational and financial performance. The company continues to increase its market share and expand geographic base with the help of acquisitions. Stericycle's focus on providing regulated business-to-business services to smaller businesses should expand its offerings and boost the company's profits. However, decline in Communication and Related Services businesses is weighing on Stericycle’s top line. A highly-competitive waste management industry will put Stericycle under pricing pressure. International presence exposes Stericycle to foreign currency exchange rate risks. High debt may limit the company’s future expansion and worsen its risk profile." (3/4/2019)
- 2. Robert W. Baird analysts commented, "Driven by the successful turnaround efforts at Terminix and solid performance in FSG, adjusted EBITDA of $105M was in line with our estimate and beat the Street’s $101M estimate; revenues of $496M also beat our/Street’s $489M/$486M estimates. Management raised FY2018 revenue guidance to $1,885-1,900M ($1,875M-$1,890M previously), owing to the transformation efforts and performance of acquisitions at Terminix. The company reiterated adjusted EBITDA guidance of $425-435M, as it continues to invest in the business to create sustainable, long-term growth. Maintain Outperform." (11/6/2018)
Has Stericycle been receiving favorable news coverage?
Media headlines about SRCL stock have trended somewhat positive recently, InfoTrie Sentiment Analysis reports. InfoTrie ranks the sentiment of press coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Stericycle earned a media sentiment score of 1.3 on InfoTrie's scale. They also gave headlines about the business services provider a news buzz of 2.0 out of 10, indicating that recent press coverage is very unlikely to have an impact on the company's share price in the next few days.
Who are some of Stericycle's key competitors?
What other stocks do shareholders of Stericycle own?
Who are Stericycle's key executives?
Stericycle's management team includes the folowing people:
- Mr. Charles A. Alutto, CEO & Director (Age 53)
- Mr. Daniel V. Ginnetti, Exec. VP & CFO (Age 50)
- Ms. Ruth-Ellen Abdulmassih, Advisor (Age 57)
- Ms. Cindy J. Miller, Pres, COO & Director (Age 56)
- Mr. Richard Joseph Hoffman, Sr. VP & Chief Accounting Officer (Age 52)
Who are Stericycle's major shareholders?
Stericycle's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Clarkston Capital Partners LLC (4.52%), Mondrian Investment Partners LTD (1.18%), Global Thematic Partners LLC (0.82%), Reinhart Partners Inc. (0.56%), Smith Graham & Co. Investment Advisors LP (0.16%) and Retirement Systems of Alabama (0.12%). Company insiders that own Stericycle stock include Brian P Anderson, Charles A Alutto, Daniel Ginnetti, Jack W Schuler, John Patience, Mark C Miller and Thomas D Brown. View Institutional Ownership Trends for Stericycle.
Which major investors are selling Stericycle stock?
SRCL stock was sold by a variety of institutional investors in the last quarter, including Schaper Benz & Wise Investment Counsel Inc. WI, Fulton Bank N.A., Global Thematic Partners LLC, Autus Asset Management LLC, Mondrian Investment Partners LTD, Wendell David Associates Inc., Creative Planning and Oppenheimer & Co. Inc.. Company insiders that have sold Stericycle company stock in the last year include Brian P Anderson, Charles A Alutto, Daniel Ginnetti, John Patience, Mark C Miller and Thomas D Brown. View Insider Buying and Selling for Stericycle.
Which major investors are buying Stericycle stock?
SRCL stock was purchased by a variety of institutional investors in the last quarter, including Clarkston Capital Partners LLC, Roubaix Capital LLC, First American Trust FSB, Smith Graham & Co. Investment Advisors LP, Reinhart Partners Inc., Oppenheimer Asset Management Inc., Addison Capital Co and Gofen & Glossberg LLC IL. Company insiders that have bought Stericycle stock in the last two years include Brian P Anderson and Jack W Schuler. View Insider Buying and Selling for Stericycle.
How do I buy shares of Stericycle?
Shares of SRCL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Stericycle's stock price today?
One share of SRCL stock can currently be purchased for approximately $57.75.
How big of a company is Stericycle?
Stericycle has a market capitalization of $5.24 billion and generates $3.49 billion in revenue each year. The business services provider earns $-244,700,000.00 in net income (profit) each year or $4.45 on an earnings per share basis. Stericycle employs 22,500 workers across the globe.
What is Stericycle's official website?
How can I contact Stericycle?
Stericycle's mailing address is 28161 NORTH KEITH DRIVE, LAKE FOREST IL, 60045. The business services provider can be reached via phone at 847-367-5910 or via email at [email protected]
MarketBeat Community Rating for Stericycle (NASDAQ SRCL)
MarketBeat's community ratings are surveys of what our community members think about Stericycle and other stocks. Vote "Outperform" if you believe SRCL will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SRCL will underperform the S&P 500 over the long term. You may vote once every thirty days.
